LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

DexCom Inc

Suletud

SektorTervishoid

85.47 -0.21

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

84.68

Max

85.96

Põhinäitajad

By Trading Economics

Sissetulek

-46M

105M

Müük

-78M

1B

P/E

Sektori keskmine

63.947

56.602

Aktsiakasum

0.32

Kasumimarginaal

10.174

Töötajad

10,200

EBITDA

-109M

134M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+15.48% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

24. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-1.2B

33B

Eelmine avamishind

85.68

Eelmine sulgemishind

85.47

Uudiste sentiment

By Acuity

100%

0%

371 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

DexCom Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. okt 2024, 09:10 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26. juuli 2024, 20:16 UTC

Tulu

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26. juuli 2024, 09:13 UTC

Peamised uudised
Kuumad aktsiad

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26. juuli 2024, 08:56 UTC

Peamised uudised

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27. juuni 2024, 16:01 UTC

Tulu

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

DexCom Inc Prognoos

Hinnasiht

By TipRanks

15.48% tõus

12 kuu keskmine prognoos

Keskmine 98.93 USD  15.48%

Kõrge 109 USD

Madal 85 USD

Põhineb 17 Wall Streeti analüütiku instrumendi DexCom Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

17 ratings

16

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

71.66 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Neutral Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.